Zafer Buyukterzi

Zafer Buyukterzi

Auto-generated profile, based on publicly available information

Zafer Buyukterzi

Department of Cardiology Konya City Hospital Konya Turkey

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2017 in Biomarkers in Medicine
Verified
Journal Article
Closed access
ZBZafer Buyukterzi
Zafer Buyukterzi
UCUmmugulsum Can
Ummugulsum Can
SASertac Alpaydin
Sertac Alpaydin
AGAsuman Guzelant
Asuman Guzelant
SKSukru Karaarslan
Sukru Karaarslan
KGKadri Murat Gurses
Kadri Murat Gurses
Aims: In this study, we aimed to investigate whether serum S100A8, S100A9 and S100A12 levels were markers of acute coronary syndrome (ACS). Materials & methods: Patients who underwent coronary angiography and/or percutaneous coronary interventions between June 2015–October 2015 were consecutively recruited in this study and categorized three groups each containing 30 patients (normal coronary arteries, stable coronary artery disease, and acute coronary syndrome). Baseline characteristics, including co- morbidities and medications, were recorded and serum S100A8, S100A9, S100A12, and C- reactive protein levels were measured besides routine laboratory tests. Results: A total of 90 patients (63.00 [56.00–73.00] years, 62.89% male) have been included. None of the groups differed from each other regarding baseline characteristics (p > 0.05). S100A9 levels were elevated in ACS when compared with the normal coronary arteries (p = 0.033) and S100A12 levels were found to be elevated in ACS when compared with both ...

1 June 2017 in Blood Pressure Monitoring
Verified
Journal Article
Closed access
PDF file
SASertac Alpaydin
Sertac Alpaydin
YTYasar Turan
Yasar Turan
MCMustafa Caliskan
Mustafa Caliskan
ZCZuhal Caliskan
Zuhal Caliskan
FAFeyza Aksu
Feyza Aksu
HMHaldun Muderrisoglu
Haldun Muderrisoglu
Morning blood pressure (BP) surge (MBPS) is defined as an excessive increase in the morning BP from the lowest systolic BP during sleep and is reported as a risk factor for cardiovascular events in current clinical studies. In this study, we aimed to investigate the relationship between MBPS and carotid intima-media thickness (C-IMT) in prehypertensive patients. We evaluated the association between the rate of BP variation derived from ambulatory BP monitoring and C-IMT in patients with prehypertension. One hundred and seventy patients with prehypertension were included in the study. All office BP measurements and ambulatory 24-h, day-time, and night-time measurements were similar between each group. C-IMT [0.60 (range: 0.57–0.65) vs. 0.55 (range: 0.50–0.60) cm; P<0.001] and the mean platelet volume [8.7 (range: 7.9–9.1) vs. 7.9 (range: 7.3–8.8) fl; P=0.002] were significantly higher in the greater MBPS group than the lower group. In multivariate analysis, male sex [odds ratio (OR): 2.271, confidence interval (CI): 1.011–5.100, P=0.047], greater MBPS (OR: 8.474, CI: 3.623–19.608, P<0.001), and elevated mean platelet volume levels (OR: 3.359, CI: 1.978–5.705, P<0.001) were found to be independent predictors of greater C-IMT in prehypertensive patients. Our study suggests that greater MBPS is associated independently with C-IMT in prehypertensive patients.

18 August 2025 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
HTHüseyin TEZCAN
Hüseyin TEZCAN
ZBZafer Büyükterzi
Zafer Büyükterzi
Ramadan fasting involves abstaining from food and drink from dawn to sunset, yet its impact on blood pressure (BP) and kidney function in newly diagnosed hypertensive patients remains unclear. This retrospective study examined 200 newly diagnosed hypertensive patients from Konya, Turkey, during Ramadan 2023. Half of the patients (n = 100) observed daily fasting throughout Ramadan, while the other half (n = 100) did not. All patients received a diuretic‐containing regimen consisting of an angiotensin‐converting enzyme inhibitor or angiotensin receptor blocker combined with hydrochlorothiazide. Baseline clinical and laboratory data, including serum creatinine and estimated glomerular filtration rate (eGFR), were compared with those obtained at a one‐month follow‐up (end of Ramadan). Both fasting and non‐fasting groups exhibited significant reductions in systolic and diastolic BP from baseline to the first month, with no statistically significant difference in final BP between the two groups. Kidney function, as indicated by creatinine levels and eGFR, remained stable in both groups, suggesting that Ramadan fasting did not adversely affect renal parameters. Modest improvements in lipid profiles were also observed in both cohorts. These findings indicate that, among newly diagnosed hypertensive patients on diuretic‐containing therapy, Ramadan fasting may be safe if accompanied by individualized clinical advice. However, larger and more prolonged studies are warranted to validate these results and explore potential variations in other hypertensive populations.

12 June 2017 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Closed access
PDF file
ZBZafer Buyukterzi
Zafer Buyukterzi
ÜCÜmmügülsüm Can
Ümmügülsüm Can
SASertac Alpaydin
Sertac Alpaydin
AGAsuman Guzelant
Asuman Guzelant
SKSukru Karaarslan
Sukru Karaarslan
KGKadri Murat Gurses
Kadri Murat Gurses

1 August 2020 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
MMMehmet Mustu
Mehmet Mustu
KGKadri Murat Gurses
Kadri Murat Gurses
MAMehmet Sertac Alpaydin
Mehmet Sertac Alpaydin
SKSukru Karaarslan
Sukru Karaarslan
MBMeral Buyukterzi
Meral Buyukterzi
ZBZafer Buyukterzi
Zafer Buyukterzi